Cord Blood America, Inc. (CBAI) Provides Investor Update on Argentina Subsidiary
Cord Blood America, Inc., the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children, today provided shareholders with a performance update of Biocordcell Argentina S.A. (BioCells, Inc.), which is 50.1 percent owned by Cord Blood America. "January through August revenues in 2011 are up 40 percent to $1.18 million (U.S.)," said Diego Rissola, president of BioCells, Inc. "The increase in revenues reflects the fact that we have established franchises in six provinces in Argentina and we opened an office in Miami, Florida, to service the Latin American population there. We are…